Hematopoietic Stem Cell TransplantationTransplantation, HomologousStem Cell TransplantationGraft vs Host DiseaseTransplantation ConditioningBone Marrow TransplantationPeripheral Blood Stem Cell TransplantationTransplantation, AutologousHematologic NeoplasmsTransplantation ChimeraStem CellsGraft vs Leukemia EffectTreatment OutcomeTissue DonorsMyeloablative AgonistsBusulfanGraft vs Tumor EffectVidarabineRecurrenceRemission InductionLymphocyte TransfusionGraft SurvivalHistocompatibility TestingImmunosuppressive AgentsRetrospective StudiesLeukemia, Myeloid, AcuteMultiple MyelomaLeukemiaSiblingsCord Blood Stem Cell TransplantationSurvival AnalysisMinor Histocompatibility AntigensLeukemia, Myelogenous, Chronic, BCR-ABL PositiveCombined Modality TherapyWhole-Body IrradiationCytomegalovirus InfectionsLymphocyte DepletionSurvival RateHistocompatibilityHematopoietic Stem CellsDisease-Free SurvivalSalvage TherapyAntilymphocyte SerumLiver TransplantationMyelodysplastic SyndromesVirus ActivationPrecursor Cell Lymphoblastic Leukemia-LymphomaNeoplasm, ResidualTime FactorsMelphalanChimerismAcute DiseaseHepatic Veno-Occlusive DiseaseT-LymphocytesCyclophosphamideFollow-Up StudiesMesenchymal Stem Cell TransplantationAnemia, AplasticHematopoietic Stem Cell MobilizationAntineoplastic Combined Chemotherapy ProtocolsCytomegalovirusMortalityHLA AntigensPrognosisCell TransplantationPrimary MyelofibrosisHematologic DiseasesKidney TransplantationTransplantation ImmunologyEmbryonic Stem CellsAntigens, CD34ImmunosuppressionLeukemia, Myeloid, Accelerated PhaseAntibodies, NeoplasmCytarabineRoseolovirus InfectionsLymphoproliferative DisordersLeukemia, MyeloidImmunocompromised HostBenzamidesAdult Stem CellsNuclear FamilyAntineoplastic AgentsFusion Proteins, bcr-ablInfectionHodgkin DiseaseGraft RejectionReceptors, Purinergic P2X5PyrimidinesLeukocyte TransfusionProspective StudiesGranulocyte Colony-Stimulating FactorGanciclovirLymphoma, Non-HodgkinFatal OutcomeImmunotherapy, AdoptiveTransplantation, IsogeneicPiperazinesRisk FactorsCyclosporine